AMICUS THERAPEUTICS, INC. 4 SEC Filings

Filed On	Filing
27 Apr 2026	Form 4: Wheeler Craig A, Director Returned 84,631 shares to the issuer ($1.23M) · Disposed of 313,630 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Mcglynn Margaret G, Director Returned 94,631 shares to the issuer ($1.37M) · Disposed of 303,630 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Whitman Burke W, Director Returned 118,598 shares to the issuer ($1.72M) · Disposed of 273,885 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Sblendorio Glenn, Director Returned 142,564 shares to the issuer ($2.07M) · Disposed of 303,630 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Roberts Eiry, Director Returned 76,275 shares to the issuer ($1.11M) · Disposed of 233,861 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Bleil Lynn Dorsey, Director Returned 113,941 shares to the issuer ($1.65M) · Disposed of 281,999 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Kelly Michael Aaron, Director Returned 72,468 shares to the issuer ($1.05M) · Disposed of 229,347 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Raab Michael, Director Returned 115,857 shares to the issuer ($1.68M) · Disposed of 303,630 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Prout Samantha, Chief Accounting Officer Returned 125,951 shares to the issuer ($1.83M) · Disposed of 205,022 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Castelli Jeff, Chief Development Officer Returned 427,089 shares to the issuer ($6.19M) · Disposed of 673,537 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Clark David Michael, Chief People Officer Returned 221,811 shares to the issuer ($3.22M) · Disposed of 675,720 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Rosenberg Ellen, Chief Legal Officer Returned 478,898 shares to the issuer ($6.94M) · Disposed of 786,095 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Harford Simon N.r., Chief Financial Officer Returned 143,595 shares to the issuer ($2.08M) · Disposed of 438,633 Stock Options (right to buy) (Disposition to Issuer)
27 Apr 2026	Form 4: Campbell Bradley L, Director Returned 1,008,680 shares to the issuer ($14.6M) · Disposed of 1,964,409 Stock Options (right to buy) (Disposition to Issuer)
04 Mar 2026	Form 4: Campbell Bradley L, Director Sold 22,500 shares ($323K)
22 Jan 2026	Form 4: Campbell Bradley L, Director Received 75,000 shares by exercise or conversion ($458K) · Sold 75,000 shares ($1.07M)
06 Jan 2026	Form 4: Rosenberg Ellen, Chief Legal Officer Gave up 13,426 shares to cover exercise price or tax ($192K) · Gave up 29,683 shares to cover exercise price or tax ($424K)
06 Jan 2026	Form 4: Castelli Jeff, Chief Development Officer Gave up 6,905 shares to cover exercise price or tax ($98.5K) · Gave up 23,102 shares to cover exercise price or tax ($330K)
06 Jan 2026	Form 4: Prout Samantha, Chief Accounting Officer Gave up 3,443 shares to cover exercise price or tax ($49.1K) · Gave up 12,240 shares to cover exercise price or tax ($175K)
06 Jan 2026	Form 4: Clark David Michael, Chief People Officer Gave up 5,381 shares to cover exercise price or tax ($76.8K) · Gave up 18,498 shares to cover exercise price or tax ($264K)

Comments